Age

20–74

Sex

ALL

Healthy volunteers

Not accepted

Subjects who participated in Study 275-08-003 and meet all of the criteria described below.
* Patients who did not reach ACR20, and prematurely discontinued Study 275-08-003 at Week 16 or completed Study 275-08-003 by Week 24.

Patients who experienced an important protocol deviation as mentioned below during Study 275-08-003.
Patients who received live or attenuated vaccines during Study 275-08-003 (Except for influenza or pneumococcal vaccines).
Patients who were found to have tuberculosis on a chest X-ray during Study 275-08-003.
Patients who required treatment for the same infection at two or more different times during Study 275-08-003
Women who are pregnant, are lactating, of childbearing potential and wish to conceive during the study and post-study 3 months.
Patients whom the investigator has decided to be inappropriate for participation in the study

Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients